ProShares Ultra Nasdaq Biotechnology

Lønnsomhet i seks måneder: -17.87%
Industri: Leveraged Equities

Kategori	Dele, %	Mengde
Healthcare	66.28	195

Utveksling	Dele, %	Mengde
NASDAQ	97.44	190
New York Stock Exchange	2.56	5

Del etter land

Land	Mengde	Bedrifter
United States	164	Gilead Sciences (dele - 6.44%) Regeneron (dele - 5.73%) Amgen (dele - 5.37%) Vertex (dele - 5.14%) Alnylam Pharmaceuticals, Inc. (dele - 2.29%) Biogen (dele - 1.91%) Moderna (dele - 1.75%) Illumina (dele - 1.39%) Summit Therapeutics Inc. (dele - 1.15%) United Therapeutics Corporation (dele - 1.01%) Incyte (dele - 0.9731%) Viatris (dele - 0.9415%) BioMarin Pharmaceutical (dele - 0.8975%) Royalty Pharma plc (dele - 0.8455%) Vaxcyte, Inc. (dele - 0.8426%) Neurocrine Biosciences (dele - 0.8013%) Sarepta Therapeutics, Inc. (dele - 0.7843%) Insmed Incorporated (dele - 0.7807%) Medpace Holdings, Inc. (dele - 0.7435%) Halozyme Therapeutics, Inc. (dele - 0.5272%) Intra-Cellular Therapies, Inc. (dele - 0.524%) Exelixis (dele - 0.5191%) Revolution Medicines, Inc. (dele - 0.4831%) Cytokinetics, Incorporated (dele - 0.4262%) Ionis Pharmaceuticals (dele - 0.4108%) Nuvalent, Inc. (dele - 0.4032%) Blueprint Medicines Corporation (dele - 0.3718%) Krystal Biotech, Inc. (dele - 0.3466%) Madrigal Pharmaceuticals, Inc. (dele - 0.3304%) BridgeBio Pharma, Inc. (dele - 0.3228%) Ultragenyx Pharmaceutical Inc. (dele - 0.3188%) ADMA Biologics, Inc. (dele - 0.2976%) Denali Therapeutics Inc. (dele - 0.2915%) Axsome Therapeutics, Inc. (dele - 0.289%) Apellis Pharmaceuticals, Inc. (dele - 0.2874%) Arcellx, Inc. (dele - 0.2863%) Avidity Biosciences, Inc. (dele - 0.2836%) Immunovant, Inc. (dele - 0.2805%) Crinetics Pharmaceuticals, Inc. (dele - 0.2766%) Legend Biotech Corporation (dele - 0.2709%) Dyne Therapeutics, Inc. (dele - 0.2237%) Rhythm Pharmaceuticals, Inc. (dele - 0.2173%) Amicus Therapeutics, Inc. (dele - 0.2148%) Guardant Health, Inc. (dele - 0.2039%) Kymera Therapeutics, Inc. (dele - 0.1893%) Iovance Biotherapeutics, Inc. (dele - 0.1891%) Twist Bioscience Corporation (dele - 0.182%) PTC Therapeutics, Inc. (dele - 0.1808%) ACADIA Pharmaceuticals Inc. (dele - 0.1793%) Geron Corporation (dele - 0.1782%) SpringWorks Therapeutics, Inc. (dele - 0.1751%) IDEAYA Biosciences, Inc. (dele - 0.1747%) Protagonist Therapeutics, Inc. (dele - 0.1746%) Agios Pharmaceuticals, Inc. (dele - 0.1718%) Veracyte, Inc. (dele - 0.1716%) Arrowhead Pharmaceuticals, Inc. (dele - 0.1715%) Myriad Genetics, Inc. (dele - 0.1711%) Janux Therapeutics, Inc. (dele - 0.1665%) Amphastar Pharmaceuticals, Inc. (dele - 0.1618%) NantKwest, Inc. (dele - 0.1572%) Vericel Corporation (dele - 0.1498%) Vera Therapeutics, Inc. (dele - 0.1465%) Harmony Biosciences Holdings, Inc. (dele - 0.1447%) Intellia Therapeutics, Inc. (dele - 0.1444%) Beam Therapeutics Inc. (dele - 0.1395%) Keros Therapeutics, Inc. (dele - 0.1336%) Rocket Pharmaceuticals, Inc. (dele - 0.1258%) Akero Therapeutics, Inc. (dele - 0.1239%) Ligand Pharmaceuticals Incorporated (dele - 0.1239%) MannKind Corporation (dele - 0.1205%) Mirum Pharmaceuticals, Inc. (dele - 0.1188%) Edgewise Therapeutics, Inc. (dele - 0.1184%) Novavax, Inc. (dele - 0.1172%) Supernus Pharmaceuticals, Inc. (dele - 0.1163%) Arvinas, Inc. (dele - 0.1136%) BioCryst Pharmaceuticals, Inc. (dele - 0.1092%) Harrow Health, Inc. (dele - 0.1065%) Recursion Pharmaceuticals, Inc. (dele - 0.1057%) Kura Oncology, Inc. (dele - 0.1025%) Syndax Pharmaceuticals, Inc. (dele - 0.1016%) Dynavax Technologies Corporation (dele - 0.0975%) Nurix Therapeutics, Inc. (dele - 0.0975%) Ocular Therapeutix, Inc. (dele - 0.0932%) Ardelyx, Inc. (dele - 0.0917%) ARS Pharmaceuticals, Inc. (dele - 0.0905%) Xencor, Inc. (dele - 0.0854%) ANI Pharmaceuticals (dele - 0.085%) Collegium Pharmaceutical, Inc. (dele - 0.0843%) Tarsus Pharmaceuticals, Inc. (dele - 0.0818%) Innoviva, Inc. (dele - 0.0811%) Maravai LifeSciences Holdings, Inc. (dele - 0.0809%) Day One Biopharmaceuticals, Inc. (dele - 0.0801%) Arcutis Biotherapeutics (dele - 0.08%) Disc Medicine Opco Inc (dele - 0.0782%) Phathom Pharmaceuticals, Inc. (dele - 0.0748%) Travere Therapeutics, Inc. (dele - 0.0726%) Vir Biotechnology, Inc. (dele - 0.0705%) Enliven Therapeutics, Inc. (dele - 0.0681%) Evolus, Inc. (dele - 0.0675%) Relay Therapeutics, Inc. (dele - 0.0669%) AnaptysBio, Inc. (dele - 0.0664%) Cullinan Oncology, Inc. (dele - 0.066%) Sana Biotechnology, Inc. (dele - 0.0632%) PetIQ, Inc. (dele - 0.0604%) 4D Molecular Therapeutics, Inc. (dele - 0.0578%) Castle Biosciences, Inc. (dele - 0.0557%) 89bio, Inc. (dele - 0.0543%) Pliant Therapeutics, Inc. (dele - 0.0501%) Erasca, Inc. (dele - 0.0499%) ORIC Pharmaceuticals, Inc. (dele - 0.0478%) Ironwood Pharmaceuticals, Inc. (dele - 0.0477%) Olema Pharmaceuticals, Inc. (dele - 0.0476%) Pacira BioSciences, Inc. (dele - 0.0453%) Replimune Group, Inc. (dele - 0.0452%) Adaptive Biotechnologies Corporation (dele - 0.0451%) Terns Pharmaceuticals, Inc. (dele - 0.0439%) Scholar Rock Holding Corporation (dele - 0.0438%) Humacyte, Inc. (dele - 0.0423%) Revance Therapeutics, Inc. (dele - 0.0415%) REGENXBIO (dele - 0.041%) Savara Inc. (dele - 0.0408%) Allogene Therapeutics (dele - 0.04%) Y-mAbs Therapeutics, Inc. (dele - 0.0396%) Lexicon Pharmaceuticals, Inc. (dele - 0.0394%) Mineralys Therapeutics, Inc. (dele - 0.0386%) SIGA Technologies, Inc. (dele - 0.0377%) Arcturus Therapeutics Holdings Inc. (dele - 0.0368%) Alector, Inc. (dele - 0.0361%) OmniAb, Inc. (dele - 0.036%) Pacific Biosciences of California, Inc. (dele - 0.0349%) Prime Medicine, Inc. (dele - 0.0318%) UroGen Pharma Ltd. (dele - 0.0315%) Anavex Life Sciences Corp. (dele - 0.0309%) EyePoint Pharmaceuticals, Inc. (dele - 0.0309%) Verve Therapeutics, Inc. (dele - 0.0307%) Sage Therapeutics, Inc. (dele - 0.0304%) KalVista Pharmaceuticals, Inc. (dele - 0.03%) Phibro Animal Health Corporation (dele - 0.0299%) iTeos Therapeutics, Inc. (dele - 0.0287%) Xeris Pharmaceuticals, Inc. (dele - 0.0286%) MaxCyte, Inc. (dele - 0.0282%) Taysha Gene Therapies, Inc. (dele - 0.0267%) Lyell Immunopharma, Inc. (dele - 0.0229%) Voyager Therapeutics, Inc. (dele - 0.0225%) Editas Medicine, Inc. (dele - 0.0212%) Biomea Fusion, Inc. (dele - 0.0207%) Zentalis Pharmaceuticals, Inc. (dele - 0.0196%) Vanda Pharmaceuticals (dele - 0.0192%) MeiraGTx Holdings plc (dele - 0.0183%) Precigen, Inc. (dele - 0.0175%) Cabaletta Bio, Inc. (dele - 0.0144%) Fulcrum Therapeutics, Inc. (dele - 0.0142%) MacroGenics, Inc. (dele - 0.0137%) Caribou Biosciences, Inc. (dele - 0.0125%) Ventyx Biosciences, Inc. (dele - 0.0107%) Coherus BioSciences, Inc. (dele - 0.008%) ALX Oncology Holdings Inc. (dele - 0.0074%) 23andMe Holding Co. (dele - 0.0072%) Bluebird Bio (dele - 0.0063%) Aclaris Therapeutics, Inc. (dele - 0.0055%) Marinus Pharmaceuticals, Inc. (dele - 0.0055%) Ovid Therapeutics Inc. (dele - 0.005%) RAPT Therapeutics, Inc. (dele - 0.0042%) Reneo Pharmaceuticals, Inc. (dele - 0.0033%)
United Kingdom	6	AstraZeneca PLC (dele - 2.48%) Verona Pharma plc (dele - 0.1354%) Immunocore Holdings plc (dele - 0.0853%) Centessa Pharmaceuticals Limited (dele - 0.0605%) Bicycle Therapeutics plc (dele - 0.0581%) Autolus Therapeutics plc (dele - 0.0513%)
Netherlands	3	argenx SE (dele - 1.13%) Merus N.V. (dele - 0.2175%) uniQure (dele - 0.0186%)
France	1	Sanofi (dele - 1.08%)
Germany	3	BioNTech SE (dele - 0.7534%) CureVac N.V. (dele - 0.049%) Atai Life Sciences N.V. (dele - 0.0138%)
Denmark	2	Ascendis Pharma A/S (dele - 0.573%) Genmab A/S (dele - 0.073%)
China	2	BeiGene, Ltd. (dele - 0.5608%) Zai Lab Limited (dele - 0.0726%)
Ireland	4	Jazz Pharmaceuticals plc (dele - 0.4591%) Alkermes plc (dele - 0.3129%) Prothena Corporation plc (dele - 0.0769%) Amarin (dele - 0.016%)
Switzerland	2	CRISPR Therapeutics AG (dele - 0.2798%) AC Immune SA (dele - 0.0238%)
Canada	2	Xenon Pharmaceuticals Inc. (dele - 0.201%) AbCellera Biologics Inc. (dele - 0.0537%)
Jersey	1	NovoCure Limited (dele - 0.1259%)
Spain	1	Grifols, S.A. (dele - 0.0709%)
Singapore	1	Wave Life Sciences Ltd. (dele - 0.0445%)
Belgium	1	Galapagos NV (dele - 0.0409%)
Hong Kong	1	Hutchison China MediTech Limited (dele - 0.0336%)
Cayman Islands	1	Theravance Biopharma, Inc. (dele - 0.0267%)

Betal for abonnementet ditt

Mer funksjonalitet og data for selskaps- og porteføljeanalyse er tilgjengelig med abonnement

Abonner